4.6 Article

Brain Transcriptome-Wide Screen for HIV-1 Nef Protein Interaction Partners Reveals Various Membrane-Associated Proteins

Journal

PLOS ONE
Volume 7, Issue 12, Pages -

Publisher

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0051578

Keywords

-

Funding

  1. Prasidentenfond der Helmholtzgemeinschaft (HGF, Virtual Institute of Structural Biology)

Ask authors/readers for more resources

HIV-1 Nef protein contributes essentially to the pathology of AIDS by a variety of protein-protein-interactions within the host cell. The versatile functionality of Nef is partially attributed to different conformational states and posttranslational modifications, such as myristoylation. Up to now, many interaction partners of Nef have been identified using classical yeast two-hybrid screens. Such screens rely on transcriptional activation of reporter genes in the nucleus to detect interactions. Thus, the identification of Nef interaction partners that are integral membrane proteins, membrane-associated proteins or other proteins that do not translocate into the nucleus is hampered. In the present study, a split-ubiquitin based yeast two-hybrid screen was used to identify novel membrane-localized interaction partners of Nef. More than 80% of the hereby identified interaction partners of Nef are transmembrane proteins. The identified hits are GPM6B, GPM6A, BAP31, TSPAN7, CYB5B, CD320/TCblR, VSIG4, PMEPA1, OCIAD1, ITGB1, CHN1, PH4, CLDN10, HSPA9, APR-3, PEBP1 and B3GNT, which are involved in diverse cellular processes like signaling, apoptosis, neurogenesis, cell adhesion and protein trafficking or quality control. For a subfraction of the hereby identified proteins we present data supporting their direct interaction with HIV-1 Nef. We discuss the results with respect to many phenotypes observed in HIV infected cells and patients. The identified Nef interaction partners may help to further elucidate the molecular basis of HIV-related diseases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemistry & Molecular Biology

Inhibition of Polyglutamine Misfolding with D-Enantiomeric Peptides Identified by Mirror Image Phage Display Selection

Pauline Elisabeth Kolkwitz, Jeannine Mohrlueder, Dieter Willbold

Summary: Stabilizing protein conformation with D-enantiomeric peptide ligands may offer a promising therapeutic approach for heritable polyglutamine diseases by preventing aggregation and promoting monomerization. A specific D-enantiomeric peptide, QF2D-2, showed potential for inhibiting aggregation of polyglutamine-containing proteins, suggesting a possible treatment option for spinal and bulbar muscular atrophy and other related diseases.

BIOMOLECULES (2022)

Article Chemistry, Medicinal

Design of D-Amino Acids SARS-CoV-2 Main Protease Inhibitors Using the Cationic Peptide from Rattlesnake Venom as a Scaffold

Raphael J. Eberle, Ian Gering, Markus Tusche, Philipp N. Ostermann, Lisa Muller, Ortwin Adams, Heiner Schaal, Danilo S. Olivier, Marcos S. Amaral, Raghuvir K. Arni, Dieter Willbold, Monika A. Coronado

Summary: The C30 endopeptidase is crucial for the life cycle of SARS-CoV-2 and is a potential drug target. Crotamine, a peptide isolated from rattlesnake venom, has shown promising activities and derivatives such as L-peptides have exhibited inhibitory effects on 3CL protease. D-peptides have shown potential as a prototype for peptide-based drugs targeting viral protease 3CL(pro).

PHARMACEUTICALS (2022)

Article Biochemistry & Molecular Biology

CDC42-IQGAP Interactions Scrutinized: New Insights into the Binding Properties of the GAP-Related Domain

Niloufar Mosaddeghzadeh, Silke Pudewell, Farhad Bazgir, Neda S. Kazemein Jasemi, Oliver H. F. Krumbach, Lothar Gremer, Dieter Willbold, Radovan Dvorsky, Mohammad R. Ahmadian

Summary: This study provides evidence for the mechanistic framework model that IQGAP GRD might act as a 'scaffolding domain' by binding CDC42 irrespective of its nucleotide-bound forms. The study found that the binding affinity of GRD1 and GRD2 to CDC42 is lower compared to C794/C795, and mutation of the switch regions of CDC42 greatly affected the binding of C794/C795 but had little effect on GRD1 and no effect on GRD2.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Virology

A So-Far Overlooked Secondary Conformation State in the Binding Mode of SARS-CoV-2 Spike Protein to Human ACE2 and Its Conversion Rate Are Crucial for Estimating Infectivity Efficacy of the Underlying Virus Variant

Marc Sevenich, Joop van den Heuvel, Ian Gering, Jeannine Mohrlueder, Dieter Willbold

Summary: The binding between the spike protein of SARS-CoV-2 and hACE2 is a two-step interaction, which enhances the stability of the complex. This interaction is not only present in the wild type strain but also in the B.1.1.7 variant, with an increased transition rate. These findings are important for understanding the infectivity and characterizing emerging variants of SARS-CoV-2 spike proteins.

JOURNAL OF VIROLOGY (2022)

Article Microbiology

Riboflavin, a Potent Neuroprotective Vitamin: Focus on Flavivirus and Alphavirus Proteases

Raphael J. Eberle, Danilo S. Olivier, Marcos S. Amaral, Carolina C. Pacca, Mauricio L. Nogueira, Raghuvir K. Arni, Dieter Willbold, Monika A. Coronado

Summary: This study demonstrates the inhibitory potential of the water-soluble vitamin riboflavin against NS2B/NS3(pro) of ZIKV and YFV and nsP2(pro) of CHIKV, and its ability to inhibit the viral entry of CHIKV. Molecular dynamics simulations validate the repurposing of riboflavin as a promising molecule in drug development against these viruses.

MICROORGANISMS (2022)

Article Biochemistry & Molecular Biology

Met/Val129 polymorphism of the full-length human prion protein dictates distinct pathways of amyloid formation

Thomas Pauly, Najoua Bolakhrif, Jesko Kaiser, Luitgard Nagel-Steger, Lothar Gremer, Holger Gohlke, Dieter Willbold

Summary: The polymorphism of Methionine/valine at position 129 in the human prion protein (huPrP) is closely associated with the pathogenic phenotype, disease progression, and onset age of neurodegenerative diseases. This study investigates the influence of the amino acid type at position 129 on the structural properties of huPrP using various biophysical techniques. The results reveal differences in aggregation propensity and oligomer content between the 129M and 129V variants, leading to divergent pathways for amyloid formation. The study also identifies intramolecular interactions responsible for the enhanced monomer stability of the 129M variant.

JOURNAL OF BIOLOGICAL CHEMISTRY (2022)

Article Biochemistry & Molecular Biology

Structure and Dynamics of Human Chemokine CCL16-Implications for Biological Activity

Oliver H. Weiergraeber, Dusan Petrovic, Andreas Kislat, Martin Pattky, Judith Fabig, Renu Batra-Safferling, Jan Schulte Am Esch, Karen Haenel, Carolin Huhn, Birgit Strodel, Bernhard Homey, Dieter Willbold

Summary: CCL16 is primarily synthesized by hepatocytes, circulates in the blood as a full-length protein, and the C-terminal extension may impair its biological activity modulation.

BIOMOLECULES (2022)

Article Biochemistry & Molecular Biology

Discovery of All-D-Peptide Inhibitors of SARS-CoV-2 3C-like Protease

Raphael J. Eberle, Marc Sevenich, Ian Gering, Lara Scharbert, Birgit Strodel, Nils A. . Lakomek, Karoline Santur, Jeannine Mohrlueder, Monika A. . Coronado, Dieter Willbold

Summary: A novel and efficient next-generation sequencing (NGS) supported phage display selection strategy was used to identify a set of peptide ligands that inhibit the SARS-CoV-2 3CL protease. These ligands have the potential to be lead compounds for therapeutic development and address limitations associated with current L-peptide inhibitors.

ACS CHEMICAL BIOLOGY (2023)

Article Biochemistry & Molecular Biology

Stabilization of Monomeric Tau Protein by All D-Enantiomeric Peptide Ligands as Therapeutic Strategy for Alzheimer's Disease and Other Tauopathies

Tim Altendorf, Ian Gering, Beatrix Santiago-Schuebel, Selma Aghabashlou Saisan, Gueltekin Tamgueney, Markus Tusche, Dominik Honold, Sarah Schemmert, Wolfgang Hoyer, Jeannine Mohrlueder, Dieter Willbold

Summary: Alzheimer's disease and other tauopathies are caused by the misfolding and aggregation of the tau protein, leading to neurodegeneration. In this study, two all D-enantiomeric peptides were developed, which bind to monomeric tau protein and inhibit its aggregation into amyloid fibrils. These peptides show promise as potential therapeutic agents for Alzheimer's disease and other tauopathies.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Microbiology

Characteristics of the GlnH and GlnX Signal Transduction Proteins Controlling PknG-Mediated Phosphorylation of OdhI and 2-Oxoglutarate Dehydrogenase Activity in Corynebacterium glutamicum

Lea Sundermeyer, Graziella Bosco, Srushti Gujar, Melanie Brocker, Meike Baumgart, Dieter Willbold, Oliver H. Weiergraeber, Marco Bellinzoni, Michael Bott

Summary: In this study, we investigated the roles of GlnH and GlnX in the GlnH-GlnX-PknG-OdhI-OdhA signal transduction cascade in C. glutamicum, and confirmed their involvement through genetic, biochemical, and structural modeling approaches.

MICROBIOLOGY SPECTRUM (2022)

Article Pharmacology & Pharmacy

The Importance of Epigallocatechin as a Scaffold for Drug Development against Flaviviruses

Monika A. Coronado, Ian Gering, Marc Sevenich, Danilo S. Olivier, Mohammadamin Mastalipour, Marcos S. Amaral, Dieter Willbold, Raphael J. Eberle

Summary: Epigallocatechin molecules, found in green tea, have shown great potential in inhibiting flaviviruses such as Dengue, yellow fever, West Nile, and Zika. This discovery could lead to the development of more effective antiviral drugs.

PHARMACEUTICS (2023)

Article Medicine, General & Internal

Development and Implementation of an Internal Quality Control Sample to Standardize Oligomer-Based Diagnostics of Alzheimer's Disease

Marlene Pils, Alexandra Dybala, Fabian Rehn, Lara Bloemeke, Tuyen Bujnicki, Victoria Kraemer-Schulien, Wolfgang Hoyer, Detlev Riesner, Dieter Willbold, Oliver Bannach

Summary: Protein misfolding and aggregation are key factors in neurodegenerative diseases. In this study, a synthetic β-amyloid oligomer sample was developed for quality control and standardization of diagnostic methods. The combination of atomic force microscopy and fluorescence analysis showed promising results for the detection of Aβ oligomers in bodily fluids.

DIAGNOSTICS (2023)

Article Biochemistry & Molecular Biology

Oral Treatment with d-RD2RD2 Impedes Early Disease Mechanisms in SOD1*G93A Transgenic Mice but Does Not Prolong Survival

Katharina Wintz, Julia Post, Karl-Josef Langen, Dieter Willbold, Antje Willuweit, Janine Kutzsche

Summary: Amyotrophic lateral sclerosis (ALS) is a deadly disease with no cure, causing complete muscle loss and respiratory arrest. Only three symptomatic drugs have been approved by the FDA so far. RD2RD2, a new drug candidate, has shown the ability to delay symptom onset in mouse models of ALS.

BIOMEDICINES (2023)

Article Biochemistry & Molecular Biology

The Avidity of Autoreactive Alpha-Synuclein Antibodies in Leucine-Rich Repeat Kinase 2 Mutation Carriers Is Not Altered Compared to Healthy Controls or Patients with Parkinson's Disease

Alexandra Albus, Yannick Kronimus, Monika Burg-Roderfeld, Hendrik van der Wurp, Dieter Willbold, Tamar Ziehm, Richard Dodel, Jean Alexander Ross

Summary: The accumulation and aggregation of alpha-synuclein are crucial mechanisms in the development of Parkinson's disease. This study investigated the levels and binding characteristics of naturally occurring autoantibodies against alpha-synuclein in patients with Parkinson's disease and healthy controls. The results showed no significant differences in the levels or affinities of these autoantibodies between the two groups, regardless of the presence of LRRK2 gene mutations.

BIOMOLECULES (2023)

Article Cell Biology

A? oligomer concentration in mouse and human brain and its drug-induced reduction ex vivo

Bettina Kass, Sarah Schemmert, Christian Zafiu, Marlene Pils, Oliver Bannach, Janine Kutzsche, Tuyen Bujnicki, Dieter Willbold

Summary: In this study, we analyzed the concentration and size distribution of AD oligomers in different transgenic mouse models and in human brain samples. We demonstrated that the compound RD2 eliminated oligomers in mouse and human AD brain tissue, providing potential translational value from pre-clinical studies to clinical trials.

CELL REPORTS MEDICINE (2022)

No Data Available